About this event

  • Date and time Tue 26 Jan 2021 from 4:30pm to 5:30pm
  • Location Online
  • Organised by Endocrinology and Diabetes

This 3-part webinar will explore the challenges in managing heart failure and renal disease in diabetes. It will promote understanding and communication between general practitioners, cardiologists, nephrologists and endocrinologists working together to combat heart failure and diabetes.

In this first webinar, experts in their field unite to address recent clinical trial results for the management of thrombosis in diabetes and discuss new practises in the management of heart failure.

During this webinar you will:

  • Learn the management of thrombosis risk in diabetes
  • Understand the challenges in the management of heart failure and diabetes
  • Discover new practices within the field of diabetes and heart failure management 

Have you registered for part 2 and 3 yet? Sign up to them now and get part 3 for free. Please email events@rsm.ac.uk to claim your free place:

A certificate of attendance and CPD certificate with 1 CPD credit(s) per webinar of this series will be issued to those joining the webinars live. Certificates of attendance for CPD will be automatically issued after 7 days, but only where a delegate watches the webinar live in its entirety. 

10 x bursary places are available for this series. Please email endocrinology@rsm.ac.uk to claim your place.

Join in the conversation online
Follow us on Twitter: @RoySocMed 

We would like to thank our sponsors AstraZeneca and Eli Lilly and Company for their support of this webinar. Please note that the scientific programme and content has not been influenced in any way by the sponsors.

Key speakers

Professor Ramzi Ajjan

Professor of Metabolic Medicine

Speaker's biography

RA Ajjan (FRCP, MMed.Sci, PhD) is a Professor of Metabolic Medicine and an Honorary Consultant in Diabetes and Endocrinology at Leeds University and Leeds Teaching Hospitals Trust. He obtained his PhD from the University of Sheffield and completed his clinical training in Diabetes and Endocrinology at Leeds Teaching Hospitals. His team undertakes basic, translational and clinical research collectively aiming to reduce cardiovascular complications in individuals with diabetes by optimising glycaemia and ameliorating the thrombotic environment. He has over 180 publications including original articles, reviews and book chapters. His clinical practice concentrates on young adults with diabetes as well as older individuals at high risk of vascular disease. He is local R&D lead for Diabetes/Endocrinology, regional clinical research network co-lead for diabetes, endocrine and metabolic conditions, and deputy Chair of Clinical Study Group 2 at Diabetes UK. He is an Associate Editor of Diabetes and Vascular Disease Research, and member of the editorial board of International Journal of Molecular Sciences.

Professor Mark Petrie

Professor of Cardiology

Speaker's biography

Mark Petrie is Professor of Cardiology in the Institute of Cardiovascular and Medical Sciences at the University of Glasgow, and a cardiologist at the Golden Jubilee National Hospital, Glasgow, and Glasgow Royal Infirmary, UK. Professor Petrie started his studies as an undergraduate at the University of Edinburgh, UK, before training in cardiology in Glasgow. He worked as a heart failure and interventional cardiologist for many years before transferring to the University of Glasgow in 2016. Professor Petrie's research interests focus on diabetes and cardiovascular disease, heart failure, structural intervention in heart failure, revascularisation in heart failure, peripartum cardiomyopathy, microvascular disease in heart failure with preserved ejection fraction, post-myocardial infarction cardiac remodelling, iron in heart failure and cardio-oncology. Professor Petrie has leadership roles in many trials including REVIVED, REDUCE-LAP, Dapa-HF, PARADISE-MI, EMPACT-MI, FINEARTS, SUBCUT-HF, REALIZE-K, STEP-HF, RELIEHF-HF and IRONMAN.  He has been on the clinical events committees of over 40 trials, including EMPA-REG OUTCOMES, DELIVER, TRUE-HF, CARMELINA and CAROLINA. He was an author of the 2011 European Society of Cardiology (ESC) non-ST-segment elevation myocardial infarction guidelines, and a reviewer of the 2016 ESC heart failure guidelines. He was second author of the ESC position statement on diabetes and heart failure. Throughout his career, Professor Petrie has published around 180 original manuscripts including many in high-impact journals, such as New England Journal of MedicineThe LancetEuropean Heart JournalJournal of the American College of Cardiology and Circulation.



View the programme

Welcome and introduction 

Dr Ketan Dhatariya, Consultant in Diabetes and Endocrinology and Honorary Professor of Medicine, Norfolk and Norwich University Hospitals NHS Foundation Trust and Dr Abdul Lakhdar, Consultant Endocrinologist, Barts Health NHS Trust

An update on the management of thrombosis risk in diabetes

Professor Ramzi Ajjan, Professor of Metabolic Medicine

Heart failure, diabetes and SGLT2 inh: Time to change practice

Professor Mark Petrie, Professor of Cardiology

Panel discussion
Close of meeting




More from this series:

EDP50 Promo
Webinar CPD

Kidneys, heart and diabetes: Science and practice – Part 2

This 3-part webinar series will explore the challenges in managing heart failure and renal disease in diabetes. 

In this second webinar, join us to understand the newest inhibitors and receptor agonists in the treatment of diabetes put in place for cardio-renal protection.

EDP50 Promo
Webinar CPD

Kidneys, heart and diabetes: Science and practice – Part 3

This 3-part webinar series will explore the challenges in managing heart failure and renal disease in diabetes. 

In this final webinar, specialists unite to discuss adopting a multifactorial approach for therapeutics and whether cardiologists and nephrologists should be able to prescribe sodium glucose transporter-2 inhibitors (SGLT2i).

*Registration for this webinar will close 2 hours prior to the start time. You will receive the webinar link 2 hours before the meeting. Late registrations will not be accepted. 

Webinar recordings will be available for registered delegates up to 30 days after the live webinar, via Zoom. The link will be sent 24 hours after the webinar takes place. 

This webinar will be recorded and stored by the Royal Society of Medicine and may be distributed in future on various internet channels.  

Man searching computer

Join the RSM and get free access to digital learning resources

The RSM has an extensive digital learning and online e-resources platform. As a member you'll enjoy free access to a wealth of online  resources, including 5,000 subscription and open access e-journals, 2,000 e-books and 5 key medical databases, to support your clinical decision-making and research.

Become a member